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Background: Vimentin (Vim) is one of the mesenchymal markers, that are often upre-
gulated in cancer cells during epithelial-mesenchymal transition (EMT) – a process
endowing tumor cells with invasiveness, pro-metastatic potential and, arguably, cancer
stem cells (CSC) properties. It is normally seen in cytoplasm, but cell surface Vim was
also detected on cells with CSC characteristics. Vim expression may be used as a surro-
gate marker of EMT in tumor tissue samples from patients and aid in prognosis evalua-
tion. We aimed to characterize Vim expression in prostate cancer (PCa) using our
method of semiquantitative staining assessment.
Methods: Vim expression was assessed in 48 cases of PCa using immunohistochemistry
with primary rabbit polyclonal antibodies (ThermoFischer, 1:1000). UnoView Rabbit
Detection Kit was used for visualization. Specificity of staining was confirmed by
another antibody (mouse monoclonal, DAKO, 1:200) in selected cases. To assess Vim
expression semiquantitatively we proposed a weighed staining index (WSI) that takes
into account the proportion of stained cells as well as the ratios of staining intensities
and can be applied to different cellular compartments staining separately. It combines
advantages of simple ad oculus semiquantitative staining evaluation and obtaining
numerical characteristics of marker expression.
Results: Median WSI for membranous staining was 5 (0 – 52) (7, if cases without
expression were excluded), for cytoplasmic – 20.5 (0 – 64) (22.5, if cases without
expression were excluded). In 2 (4.2%) cases marker expression was absent in both
membrane and cytoplasm. WSI in PCa was significantly higher for cytoplasmic stain-
ing. However, in 3 (6.25%) cases WSI for membranous staining was higher than that
for cytoplasmic. Significant correlation was found between WSI for cytoplasmic and
membranous staining (Spearman test, r¼ 0.51, p< 0,05). However, no correlation was
found between WSI for both compartments and E-cadherin expression (as assessed by
average staining intensity score – a method similar to WSI – using Aperio software
previously).
Conclusions: Vim expression as a sign of EMT in the tumor is present in 95.8% cases of
PCa and is more prevalent in cytoplasm. WSI is a useful tool to assess Vim (and possibly
other markers) expression.
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Background: Prostate cancer is the second leading cause of cancer related deaths in
men worldwide. Heat Shock Protein 90 (Hsp90) is expressed in tumour cells at high
levels – 3-5% of total proteins – and regulates the function of oncogenes and other
tumour related proteins. Protein kinase D3 (PKD3) has a proven role in the progres-
sion of androgen-independent prostate cancer. In the present study we set out to
explore the impact of Hsp90 and PKD3, respectively, on prostate cancer growth and
their potential interaction.
Methods: We employed the DU145 and PC3 well-characterized androgen-independent
prostate cancer cell lines. Cell viability was determined by Trypan Blue exclusion cell
counting. Apoptosis analysis was performed by flow cytometry after AnnexinV and
propidium-iodide co-staining. Protein levels were detected by western blot and pro-
tein-protein interactions were investigated by co-immunoprecipitation.
Results: We found that the clinically used Hsp90 inhibitor ganetespib induced apopto-
sis and significantly reduced the viability of the androgen-independent DU145 and
PC3 cell lines. The pan-PKD inhibitor CRT0066101 also decreased cell viability of the
prostate cancer cells in a dose-dependent manner. Further, we demonstrated that gane-
tespib reduced PKD3 protein level in a concentration-dependent manner and induced
its proteasomal degradation. Finally, a co-immunoprecipitation study revealed a physi-
cal connection between PKD3 and Hsp90.
Conclusions: We identified and confirmed an Hsp90-PKD3 chaperone client interac-
tion, which may be important in prostate cancer cell survival. Further studies are under
way to characterize the biological significance of our findings. Our results contribute to
better understand the pathological signalling of androgen-independent prostate cancer
cells and to find novel treatment strategies.
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Background: Resistance to androgen receptor signaling is arguably the principal hall-
mark of lethal prostate cancer. Several mechanisms account for this resistance, includ-
ing mutations in the AR, restoration of signaling downstream of the pharmacological
blocking and activation of alternative oncogenic pathways.
Methods: We used the Nkx3.1CreERT2/þ; Ptenfloxed/floxed; p53floxed/floxed
(NPp53) mice that develop CRPC upon castration and undergo neuroendocrine differ-
entiation with anti-AR treatment to isolate Enzalutamide resistance prostate cancer
cells.
Results: Recently, we showed that activation of the chromatin remodeler Nsd2 is
required for PCa metastasis and is strongly associated to tumor progression, and that
its silencing markedly reduced the metastatic burden and increased survival. Our cur-
rent data indicates that Nsd2 silencing sensitizes PCa cells to anti-AR treatment. Nsd2
KO using CRISPR/Cas9 resulted in a markedly enhanced efficacy of Enzalutamide and
a significant reduction of AR transcriptional activity with either Enzalutamide or
Abiraterone using two different reporter assays. Next, To identify Nsd2-dependent AR
co-regulators we immunoprecipitated chromatin-bound endogenous AR in NPp53
cells and NPp53-Nsd2KO and performed nano-LC-MS/MS mass spectrometry on the
purified peptide mix. In particular, data indicates that AR association with SWI/SNF
members is stronger in the absence of Nsd2, suggesting that Nsd2 overexpression might
impair AR interaction to the SWI/SNF complex. We next tested whether Nsd2 in fact
binds SWI/SNF subunits by co-immunoprecipitation in the NPp53 cells and whether
BAF155, BAF170 and BRG1 association to AR increases in the absence of Nsd2. As sus-
pected, there is a remarkable increase in the binding of AR to SWI/SNF subunits
BAF155, BAF170 and BRG1 in the absence of Nsd2.
Conclusions: Together, our data suggests that the mechanisms by which Nsd2 overex-
pression drives aggressive castration resistant and androgen independent PCa may be
in part through destabilizing the AR-SWI/SNF interaction and altering the specificity
of the AR cistrome. Ongoing work will further elucidate this by analyzing chromatin
accessibility data coupled with transcriptomics and ChIPseq data for the AR and the
BAF170, BAF155 and Brg1 SWI/SNF subunits.
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Background: In HT29 cells, an interplay between self-DNA-induced TLR9-signaling
and autophagy response was found with significant effects on cell survival and kinetic
parameters. The IGF/IGF1R system plays a determinant role in the pathogenesis and
progression of colorectal cancer. This pathway is upstream of mTORC1, a negative reg-
ulator of autophagy. I mammalian systems chronic IGF1R inhibition was shown to
attenuate autophagosome formation. The interrelated action of IGF1R inhibition and
TLR9/autophagy signaling in cancer cells has not yet been clarified. The present study
was designed to assess this complex network using HT29 colon carcinoma cells.
Methods: HT29 cells were incubated for 72 h with genomic (g), hypermethylated (m),
and fragmented (f) tumor self-DNAs, and with/without inhibitors of IGF1R (picropo-
dophyllin), autophagy (chloroquine) and TLR9 (ODN2088), respectively. Cell viability
was measured by MTT assay. Transcriptional changes of TLR9-signaling, IGF1R,
mTORC, Akt, and the autophagy process were assayed by Human v3 miRNA Assay
(NanoString). Autophagy proteins were detected by immunocytochemistry, while
morphology of apoptosis and autophagy by transmission electron microscopy (TEM).
Results: In case of autophagy g- and f-DNAs caused significant upregulation of
Beclin1, Atg16L1, LC3 mRNAs, and downregulation of mTORC, and Akt, verified by
immunocytochemistry, as well. IGF1R-inhibition alone altered inversely the
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